AboutFeaturesPricing
Sign In
Platform Comparison

Medical Intelligence vs Legacy Directories

The generational shift in aesthetic clinic data. Choose the approach that matches your commercial strategy.

The Shift

Two Generations of Aesthetic Data

Understanding the fundamental difference between directory aggregation and purpose-built intelligence.

Legacy Approach

Healthcare Directories

Aggregated healthcare data with mixed provider types. Broad coverage includes non-aesthetic facilities, requiring extensive filtering to find relevant leads.

Purpose-Built Intelligence

Verified Aesthetic Clinic Universe

Evidence-verified dataset focused exclusively on aesthetic clinics. AI Product Inference identifies injectable and device adoption. Every record is screened for aesthetic relevance.

At a Glance

Capability Comparison

CapabilityPurpose-Built Intelligence (Omnera)Legacy Directory Approach
ICP Focus✓ 100% Medical Aesthetics & DentalMixed provider types
Dataset Philosophy✓ Evidence-verified (aesthetic clinics only)Volume over relevance
Product Detection✓ AI Product Inference (proprietary)Self-reported or website mentions only
Practitioner Mapping✓ GMC/GDC/NMC specialist-to-site mappingName/role listing only
Territory Planning✓ Built-in route optimisationData export only
Field-Sales Readiness✓ Purpose-built for device launchesRequires extensive filtering
Sales Intelligence

Switch to Omnera When

If the output of your data is sales outreach, Omnera is the correct platform.

Switch to Omnera if your team is responsible for...

Launching a new device or product line. Territory planning for field sales teams. Identifying clinics with current injectable and device adoption capability. Competitive brand intelligence. Outbound sales or territory execution.

Why sales teams switch

Sales teams switching from financial platforms typically see higher meeting quality at a lower cost per qualified lead. Financial data platforms charge premium pricing for historical turnover data that requires heavy filtering. Omnera delivers a verified aesthetic clinic universe where every record is actionable for outreach.

Why Legacy Databases Create Noise

Generic healthcare directories include every type of provider—physiotherapists, dentists, pharmacies, care homes, GP surgeries and general wellness businesses—that pad the headline count but have no commercial relevance to aesthetic manufacturers. Your sales reps waste time filtering through that noise instead of selling. Omnera's evidence-verified approach means every record in the 15,000+ UK aesthetic clinic universe is a genuine prospect for injectable and device sales.

Market Intelligence

Omnera vs Market-Intelligence Subscriptions

Broad healthcare intelligence subscriptions and Omnera answer different questions. Here is how to tell them apart.

Clinic-level, not aggregate

Market-intelligence subscriptions report the market in aggregate: how many providers, how many brands, which categories are growing. Omnera works at the level of the individual clinic—which brands this clinic advertises, which practitioners work there, whether a prescriber is on site, and how its reviews and booking capacity are moving.

Evidence-quoted, not counted

Every product signal in Omnera links back to its source—the treatment menu, booking page or post where it was found—with a confidence score. You open the evidence rather than trust a total.

Continuously re-verified

Clinic websites and booking pages are re-crawled on a rolling basis, and Omnera records when each brand first and last appeared at each clinic. Brand adoption, Google review velocity and booking capacity are tracked over time, so trends are built from verified clinic-level observations rather than a one-off snapshot.

Aesthetic clinics only

Broad datasets reach headline provider counts by including physiotherapists, dentists, pharmacies, care homes, GP surgeries and general wellness businesses. None of them buy aesthetic injectables or devices. Omnera covers 15,000+ UK aesthetic clinics and nothing else, so the number you see is the number you can actually sell to.

If you need a national market-sizing report, a broad subscription may suit. If your team needs to know which clinics to call this week, why, and with what evidence, that is what Omnera is built for.

Intelligence Framework

Why Financial Data is a Lagging Signal for Device Sales

The critical difference between yesterday's financials and today's clinical reality.

Lagging Signals

Turnover and financial data tell you what happened 12-18 months ago. A clinic's 2024 tax filing doesn't tell you if they have floor space, clinical intent, or practitioner capacity for a new device in 2026.

  • Revenue from completed procedures (historical)
  • Advertising spend (marketing, not adoption)
  • Consumer trends (demand, not supply)
  • Market share analysis (aggregated, not actionable)

Leading Signals

AI Product Inference tells you what devices a clinic is likely using today, from the latest public signals. Current hardware adoption signals clinical intent and practitioner capability for your next device.

  • Current injectable and device adoption signals
  • Practitioner credentials (GMC/NMC verified)
  • Treatment menu analysis (service capability)
  • Brand affiliation signals (partnership indicators)

The Intelligence Gap

Platforms that emphasize financial metrics—turnover, advertising spend, market share—are looking in the rearview mirror. When you're planning a device launch or territory strategy, you need to know which clinics have the current capability and intent to adopt, not their historical performance. AI Product Inference provides the leading signal that financial data cannot: what hardware is already on the clinic floor.

Ready to Switch to Better Sales Intelligence?

Stop paying for financial data that requires filtering. Start with purpose-built leads.

See Pricing